Common and rare variants of WNT16, DKK1 and SOST and their relationship with bone mineral density

被引:0
|
作者
Núria Martínez-Gil
Neus Roca-Ayats
Anna Monistrol-Mula
Natàlia García-Giralt
Adolfo Díez-Pérez
Xavier Nogués
Leonardo Mellibovsky
Daniel Grinberg
Susana Balcells
机构
[1] University of Barcelona,Department of Genetics, Microbiology and Statistics, Faculty of Biology
[2] IBUB,Musculoskeletal Research Group, IMIM (Hospital del Mar Medical Research Institute)
[3] IRSJD,undefined
[4] CIBERER,undefined
[5] Centro de Investigación Biomédica en Red de Fragilidad y Envejecimiento Saludable (CIBERFES),undefined
[6] ISCIII,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Numerous GWAS and candidate gene studies have highlighted the role of the Wnt pathway in bone biology. Our objective has been to study in detail the allelic architecture of three Wnt pathway genes: WNT16, DKK1 and SOST, in the context of osteoporosis. We have resequenced the coding and some regulatory regions of these three genes in two groups with extreme bone mineral density (BMD) (n = ∼50, each) from the BARCOS cohort. No interesting novel variants were identified. Thirteen predicted functional variants have been genotyped in the full cohort (n = 1490), and for ten of them (with MAF > 0.01), the association with BMD has been studied. We have found six variants nominally associated with BMD, of which 2 WNT16 variants predicted to be eQTLs for FAM3C (rs55710688, in the Kozak sequence and rs142005327, within a putative enhancer) withstood multiple-testing correction. In addition, two rare variants in functional regions (rs190011371 in WNT16b 3′UTR and rs570754792 in the SOST TATA box) were found only present in three women each, all with BMD below the mean of the cohort. Our results reinforce the higher importance of regulatory versus coding variants in these Wnt pathway genes and open new ways for functional studies of the relevant variants.
引用
收藏
相关论文
共 50 条
  • [31] COMPARISON BETWEEN SERUM DKK1 (DICKKOPF-1) EXPRESSION AND BONE MINERAL DENSITY IN PATIENTS RECEIVING BISPHOSPHONATE THERAPY AND TREATMENT NAIVE PATIENTS
    Memon, A. R.
    Harty, J.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2011, 22 : S697 - S697
  • [32] Dkk-1 inhibition increases bone mineral density in rodents.
    Grisanti, M.
    Niu, Q. T.
    Fan, W.
    Asuncion, F.
    Lee, J.
    Steavenson, S.
    Chen, Q.
    Li, J.
    Geng, Z.
    Kostenuik, P.
    Lacey, D. L.
    Simonet, W. S.
    Ominsky, M.
    Li, X.
    Richards, W. G.
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 : S25 - S25
  • [33] Dual Inhibition of the Wnt Inhibitors DKK1 and Sclerostin Promotes Fracture Healing and Increases the Density and Strength of Uninjured Bone An Experimental Study in Nonhuman Primates
    Florio, Monica
    Kostenuik, Paul J.
    Stolina, Marina
    Asuncion, Franklin J.
    Grisanti, Mario
    Ke, Hua Zhu
    Ominsky, Michael S.
    [J]. JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2023, 105 (15): : 1145 - 1155
  • [34] Anti-Sost/Dkk1 Antibody Therapy Increases Bone Formation in Old Mice, but Does Not Enhance Their Modest Response to Tibial Loading
    Lawson, Lisa
    Brodt, Michael
    Silva, Matthew
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2018, 33 : 83 - 83
  • [35] SERUM DICKKOPF1 (DKK1): RELATIONSHIP WITH BONE METABOLISM AND ATHEROSCLEROTIC DISEASE IN TYPE 2 DIABETES
    Reyes-Garcia, R.
    Rozas-Moreno, P.
    Garcia-Martin, A.
    Garcia-Fontana, B.
    Morales-Santana, S.
    Munoz-Torres, M.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2014, 25 : S191 - S191
  • [36] Insulin-dependent diabetes mellitus decreases osteoblastogenesis associated with the inhibition of Wnt signaling through increased expression of Sost and Dkk1 and inhibition of Akt activation
    Hie, Mamiko
    Iitsuka, Natsumi
    Otsuka, Tomoyo
    Tsukamoto, Ikuyo
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2011, 28 (03) : 455 - 462
  • [37] SERUM CONCENTRATIONS OF OSTEOPROTEGERIN (OPG) AND DICKKOPF-1 (DKK1) POORLY PREDICT BONE MINERAL DENSITY CHANGES AND FRACTURE INCIDENCE IN POSTMENOPAUSAL OSTEOPOROTIC WOMEN
    Rabenda, V.
    Bruyere, A.
    Cavalier, E.
    Deroisy, R.
    Lecart, M. P.
    Collette, J.
    Reginster, J. -Y.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2015, 26 : S240 - S240
  • [38] CIRCULATING SCLEROSTIN AND DICKKOPF-1 (DKK1) IN PRE-DIALYSIS CHRONIC KIDNEY DISEASE (CKD): RELATIONSHIP WITH BONE DENSITY AND ARTERIAL STIFFNESS
    Goldsmith, David
    Thambiah, S.
    Roplekar, R.
    Manghat, P.
    Manghat, P.
    Fogelman, I.
    Fraser, W.
    Hampson, G.
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 : 250 - 250
  • [39] Elevated Levels of the Wnt Antagonist DKK1 and RANKL in the Bone Marrow Environment Link Chronic Heart Failure With Osteoporosis
    Leistner, David M.
    Seeger, Florian H.
    Assmus, Birgit
    Honold, Joerg
    Fischer-Rasokat, Ulrich
    Trepels, Thomas
    Karakas, Mahir
    Roexe, Tino
    Dimmeler, Stefanie
    Zeiher, Andreas M.
    [J]. CIRCULATION, 2009, 120 (18) : S633 - S633
  • [40] Suppression of Wnt Signaling by Dkk1 Attenuates PTH-Mediated Stromal Cell Response and New Bone Formation
    Guo, Jun
    Liu, Minlin
    Yang, Dehong
    Bouxsein, Mary L.
    Saito, Hiroaki
    Galvin, R. J. Sells
    Kuhstoss, Stuart A.
    Thomas, Clare C.
    Schipani, Ernestina
    Baron, Roland
    Bringhurst, F. Richard
    Kronenberg, Henry M.
    [J]. CELL METABOLISM, 2010, 11 (02) : 161 - 171